Androgen Excess Polycystic Ovary Syndrome Society Meeting

雄激素过多多囊卵巢综合症学会会议

基本信息

  • 批准号:
    10613338
  • 负责人:
  • 金额:
    $ 1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-01-15 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract The meetings of the Androgen Excess-Polycystic Ovary Syndrome (AE-PCOS) Society are the only ones that convene the world's largest group of researchers and clinicians specifically focused on androgen-excess related disorders. Both the Annual and Update meetings bring together diverse participants to discuss their latest research findings, to encourage future research collaborations and to disseminate relevant and accurate health information to the clinical community and general public. The attendees represent several regions of the world and a variety of disciplines including medical, pediatric and reproductive endocrinology, gynecology, internal medicine, psychologists, epidemiologists, clinical nutritionists and physiologists. The two-day Annual Meeting has a well-established format consisting of multiple sessions that include invited scientific lectures, oral and poster presentations, meet-the-professor sessions, all with interactive and/or question and answer opportunities. We provide travel awards for junior investigators and child care awards to encourage the participation of the next generation of researchers and clinicians. The one-day Update Meetings, also held annually, are focused on basic science research and have a specific theme. We have demonstrated participation by females and underrepresented minorities in our meetings, membership and Board of Directors. One of the new highlights is increased collaboration with patient support groups and actively engaging patients and consumers in our meetings. The Society is composed of basic and clinical scientists and clinicians whose major interest is the etiology, diagnosis, and treatment of androgen excess disorders. The AE-PCOS Society has successfully organized 17 Annual Meetings, 4 Update Meetings which are organized as satellite meetings along with the ASRM and Endocrine Society meetings in the USA or stand alone in other international locations. The Society through its meetings and resultant publications (14 guidelines and position statements) has had significant impact on dvelopment of criteria for diagnosis, management and treatment strategies for PCOS.
项目概要/摘要 雄激素过多-多囊卵巢综合症 (AE-PCOS) 协会的会议是唯一 召集世界上最大的研究人员和临床医生小组,专门关注雄激素过多问题 相关疾病。年度会议和更新会议都汇集了不同的参与者来讨论他们的问题 最新的研究成果,鼓励未来的研究合作并传播相关和准确的信息 向临床界和公众提供健康信息。与会者代表了多个地区 世界和各个学科,包括医学、儿科和生殖内分泌学、妇科、 内科、心理学家、流行病学家、临床营养学家和生理学家。为期两天的年会 会议有一个完善的形式,由多个会议组成,其中包括邀请的科学讲座, 口头和海报展示、教授见面会,全部带有互动和/或问答 机会。我们为初级调查员提供旅行奖励和儿童保育奖励,以鼓励 下一代研究人员和临床医生的参与。还举行了为期一天的更新会议 每年,都专注于基础科学研究并有特定的主题。我们已经证明了 女性和代表性不足的少数群体参与我们的会议、会员资格和董事会。 新亮点之一是加强与患者支持团体的合作并积极吸引患者参与 和消费者参加我们的会议。该学会由基础和临床科学家以及临床医生组成,他们的 主要兴趣是雄激素过多症的病因、诊断和治疗。 AE-PCOS 协会 已成功组织17次年会、4次更新会议(以卫星会议形式组织) 与美国的 ASRM 和内分泌学会会议一起召开,或者单独在其他国际会议上召开 地点。协会通过其会议和由此产生的出版物(14 条指导方针和立场声明) 对诊断、管理和治疗策略标准的制定产生了重大影响 多囊卵巢综合症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANUJA DOKRAS其他文献

ANUJA DOKRAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANUJA DOKRAS', 18)}}的其他基金

Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
  • 批准号:
    10431620
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
  • 批准号:
    10616771
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
  • 批准号:
    9286789
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
  • 批准号:
    9924273
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
  • 批准号:
    10155513
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:
Androgen Excess Polycystic Ovary Syndrome Society Meeting
雄激素过多多囊卵巢综合症学会会议
  • 批准号:
    10237711
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:
Androgen Excess Polycystic Ovary Syndrome Society Meeting
雄激素过多多囊卵巢综合症学会会议
  • 批准号:
    10378739
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:
DIAGNOSTIC MARKERS FOR EARLY DETECTION AND TREATMENT OF PRETERM PREGNANCIES
早孕早期检测和治疗的诊断标志物
  • 批准号:
    7604876
  • 财政年份:
    2007
  • 资助金额:
    $ 1万
  • 项目类别:
CARDIOVASCULAR RISK FACTORS IN WOMEN WITH PCOS
多囊卵巢综合征女性的心血管危险因素
  • 批准号:
    7604877
  • 财政年份:
    2007
  • 资助金额:
    $ 1万
  • 项目类别:
POLYCYSTIC OVARY SYNDROME
多囊卵巢综合征
  • 批准号:
    7376983
  • 财政年份:
    2006
  • 资助金额:
    $ 1万
  • 项目类别:

相似海外基金

Metagenomic discovery and optimization of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris
针对痤疮皮肤杆菌治疗寻常痤疮的新型内溶素的宏基因组发现和优化
  • 批准号:
    10821291
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.
用于口服治疗顽固性结节性痤疮的选择性 CYP26 抑制剂。
  • 批准号:
    10822482
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Developing a novel medical-grade microneedle patch to treat acne vulgaris
开发一种新型医用级微针贴片来治疗寻常痤疮
  • 批准号:
    10053162
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Collaborative R&D
ENLIGHT : Light-sensitive Engineered Living Material for acne therapy
ENLIGHT:用于痤疮治疗的光敏工程活性材料
  • 批准号:
    EP/Y03029X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Fellowship
Smart Photodynamic Therapy for Acne by Reversibly Switchable Intersystem Crossing in Pure Organic Materials
通过纯有机材料中的可逆可切换系间交叉来治疗痤疮的智能光动力疗法
  • 批准号:
    10483461
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
  • 批准号:
    10502200
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
  • 批准号:
    10698121
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
  • 批准号:
    10404440
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
  • 批准号:
    10404436
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Study of colonization mechanism of high pathogenic Cutibacterium acnes in patients with acne and healthy individuals
高致病性痤疮皮肤杆菌在痤疮患者和健康个体中的定植机制研究
  • 批准号:
    21K15303
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了